Finding genetic proof of coronary artery disease risk

University of Minnesota School of Public Health researchers have reported two high-signal genetic markers correlated with coronary artery disease (CAD) that should help define genetic fingerprints that can signal an increased risk of developing the disease.

The results also offer biological and clinical data supporting future research into the genetic markers and their relationship to CAD, a condition that impacts more than 13 million Americans each year.

The research, led by Weihong Tang, Ph.D., M.S., M.D., a expert and assistant professor of epidemiology and community health in the University of Minnesota's School of Public, is published online today in the .

"Our research looked at two common clinical blood tests used to detect deficiencies in clotting process, the Activated Partial Thromboplastic Time (aPTT) test and the Prothrombin Time (PT) test," said Tang. "Our goal was to see if there were genetic markers or signals within the tests that could indicate which patients were at higher risk for . What we found was that within our sample, there were some highly expressive genetic markers that indeed signaled an increased risk."

Tang notes that this study focused on only white Americans, and that she and her colleagues would like to expand the survey's reach into . She hopes that a larger study will confirm the and make the information more accessible for physicians as they monitor patients for CAD risk factors.

"There is a lot of work still to be done, but our findings should set a foundation for new types of testing that will help physicians find and treat clotting diseases in the general population," said Tang.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Study clarifies parents as source of new disease mutations

19 hours ago

Scientists have long speculated that mosaicism – a biological phenomenon, in which cells within the same person have a different genetic makeup – plays a bigger role in the transmission of rare disease mutations than ...

How black truffles deal with the jumpers in their genome

Jul 31, 2014

The black truffle uses reversible epigenetic processes to regulate its genes, and adapt to changes in its surroundings. The 'methylome' - a picture of the genome regulation taking place in the truffle, is published in the ...

Gene research targets scarring process

Jul 28, 2014

Scientists have identified three genes that may be the key to preventing scar formation after burn injury, and even healing existing scars.

User comments